METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES
Provided herein are methods of treating B-cell proliferative disorders (such as Follicular Lymphoma and diffuse large B cell lymphoma) using immunoconjugates comprising anti-CD79b antibodies in combination with a Bcl-2 inhibitor (such as venetoclax) and an anti-CD20 antibody (such as obinutuzumab or...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Provided herein are methods of treating B-cell proliferative disorders (such as Follicular Lymphoma and diffuse large B cell lymphoma) using immunoconjugates comprising anti-CD79b antibodies in combination with a Bcl-2 inhibitor (such as venetoclax) and an anti-CD20 antibody (such as obinutuzumab or rituximab).
L'invention concerne des méthodes de traitement de troubles prolifératifs à cellules B (tels que le lymphome folliculaire et le lymphome diffus à grandes cellules B) à l'aide d'immunoconjugués comprenant des anticorps anti-CD79b en combinaison avec un inhibiteur de Bcl-2 (tel que le vénétoclax) et un anticorps anti-CD20 (tel que l'obinutuzumab ou le rituximab). |
---|